Adherence

Adherence features

• 

  Adherence and retention in HIV care in resource-limited settings

  Recent research on adherence to HIV treatment and retention in HIV care in resource-limited settings....

  From:HIV & AIDS treatment in practice

• 

  Once-a-day pills and other sticky problems

  Less-than-perfect adherence to a once-a-day HIV treatment carries five times more risk of treatment failure than imperfect adherence to a twice-a-day regimen. That’s one of the surprising things...

  From:HIV treatment update

• 

  In for the long haul

  With modern treatment, people with HIV can expect to live for decades and decades. But is this sustainable? How realistic is it to expect the drugs to...

  From:HIV treatment update

• 

  Using mobile phones in HIV care and prevention

  This issues provides an over view of the growing role of mobile technology in HIV care and prevention in resource-poor settings. ...

  From:HIV & AIDS treatment in practice

• 

  Adherence and long-term treatment success

  Taking your HIV medication correctly (the technical term for this is adherence) is the single most important thing you can do to make sure your HIV treatment...

  From:HIV treatment update

• 

  How to deliver good adherence support: lessons from round the world

  A review of the barriers to good adherence to antiretroviral treatment in resource-limited settings, and the evidence of which interventions most successfully support adherence....

  From:HIV & AIDS treatment in practice

• 

  A follow-up on follow-up: shifting to a community-based response to improve retention in care

  Further discussion on issues relating to retention in HIV care in low-income settings, with a focus on community-based care and task-shifting as potential solutions to...

  From:HIV & AIDS treatment in practice

Adherence in your own words

• 

  Starting treatment wasn't as scary as I thought!

  I started learning about HIV treatment soon after I was first diagnosed. I had ‘the chat’ with someone, after I got my results – I...

  From:In your own words

• 

  Getting into the habit

  I try to take my HIV drugs at the same time every day, just before bed. I used to set an alarm on my mobile,...

  From:In your own words

• 

  Holiday hassles and HRT

  A much-needed holiday. Tickets, passports, driving licence – all go in my hand luggage. I leave the toiletry bag out till the last minute. I...

  From:In your own words

• 

  The Ikea approach

  I’ve no doubt that the main reason that I’m alive and well after 15 years of living with HIV is because combination therapy became available...

  From:In your own words

• 

  'I just take the tablets and get on with my life'

  I was diagnosed HIV-positive in 1997. I'm now 65. It was a bit of a shock. It could never happen to me, after all. I...

  From:In your own words

• 

  Jewelled friends

  I have a pretty little carved wooden pill box which I’d bought in Eureka, California. It holds my tablet set for the evening if I’m...

  From:In your own words

• 

  Time will tell

  I was devastated when I got the news that I was HIV-positive. But I was lucky to have such a supportive GP. It was thanks...

  From:In your own words

Adherence news from aidsmap

• Canadian cohort shows viral suppression most likely with atazanavir/ritonavir-based HIV treatment after 6 months

  Antiretroviral therapy based on the ritonavir-boosted protease inhibitor atazanavir (Reyataz) was more likely to achieve virological suppression after six months than treatment containing the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz (Sustiva, also in the combination pill Atripla) among people ...

  11 May 2012 | Michael Carter

• Black race and depression associated with poorer adherence to HIV treatment

  African American patients have significantly poorer adherence to HIV therapy compared to other racial groups, investigators report in Journal of General Internal Medicine. Overall, black patients were 30% less likely to have optimal levels of treatment adherence than patients of ...

  08 May 2012 | Michael Carter

• Unplanned treatment interruptions involve a greater risk of virological failure than missing occasional doses

  Unstructured treatment interruptions – rather than missed doses of medication – involve a greater risk of a detectable viral load, US research published in the online edition of AIDS suggests. Investigators analysed the results of 16 clinical trials, using ...

  04 May 2012 | Michael Carter

• Only 20% of US HIV-positive people have high levels of engagement with specialist HIV care

  Only a fifth of HIV-positive people in the United States are fully engaging in specialist HIV care, research published in the online edition of the Journal of Acquired Immune Deficiency Syndromes shows. Investigators from the HIV Research Network examined rates ...

  02 May 2012 | Michael Carter

• Depression associated with socioeconomic difficulties and poor virological outcomes in UK HIV patients

  A quarter of people with HIV in the UK have a depressive disorder, according to an ongoing study presented by Dr Fiona Lampe to the British HIV Association conference in Birmingham yesterday. The study found strong ...

  20 April 2012 | Roger Pebody

• Financial incentives and motivational interviewing being used to improve adherence in young people

  St Mary’s Hospital in London is testing the use of cash incentives, in combination with motivational interviewing, in an effort to improve the adherence of a small group of HIV-positive young people. The rationale and first ...

  20 April 2012 | Roger Pebody

• Improved health, wish for normal life, main reason for loss to follow-up in Ugandan HIV patients

  Wanting to return to a ‘normal’ life after having experienced an improvement in health on HIV treatment was the key reason for loss to follow-up of three-quarters of patients who didn't return to a Kampala HIV clinic, according to ...

  17 April 2012 | Carole Leach-Lemens

• Guidelines developed to help boost rates of entry into HIV care, retention in care and levels of adherence

  New guidelines have been developed to improve the entry of patients into specialist HIV care and assist in their retention in this care. Published in the Annals of Internal Medicine, the guidelines make 37 specific recommendations and outline priorities for ...

  20 March 2012 | Michael Carter

• Four doses of PrEP a week may be enough to protect

  Further testing of drug levels in the blood and immune cells of gay men participating in the iPrEx trial of tenofovir/FTC (Truvada) pre-exposure prophylaxis (PrEP) has found that HIV infection in men assigned to Truvada was associated ...

  06 March 2012 | Gus Cairns

• A tale of two trials: how adherence is everything in PrEP

  Adherence makes all the difference to the efficacy of pre-exposure prophylaxis (PrEP), the 19th Conference on Retroviruses and Opportunistic Infections (CROI) heard today. Further data were presented from two trials of PrEP (giving anti-HIV drugs to HIV-negative people to prevent ...

  06 March 2012 | Gus Cairns

More news

Adherence news selected from other sources

• African-Americans face roadblocks to HIV therapy, untreated depression makes it worse

  African-Americans with HIV are much less likely to adhere to drug therapy than others with the disease, according to a University of Michigan study.

  03 May 2012 | University of Michigan (press release)

• Microbicides 2012 Conference: Adherence – the A-word on everyone’s lips

  In part I of this two-part blog series, Jim Pickett talks about his experiences at the recently concluded Microbicides 2012 conference in Sydney and the buzz among advocates and trial designers today.

  02 May 2012 | Mapping Pathways

• Reminders By Text Messages Help HIV Patients Stick To Antiretroviral Drug Therapy

  Mobile phones could play a valuable role in helping HIV patients to take their medication every day, according to a new Cochrane Systematic Review.

  15 March 2012 | HIV / AIDS News From Medical News Today

• US: HIV Patients Not Staying In Care

  A study from the Perelman School of Medicine at the University of Pennsylvania, reveals that only approximately 75% of individuals in the U.S. with HIV/AIDS consistently stay in care. The study, published online this week in AIDS, is the first to provide a comprehensive national estimate of HIV care retention and information about which patients are more likely to remain in care.

  08 March 2012 | HIV / AIDS News From Medical News Today

• Adherence to bipolar medications may also promote adherence to antiretroviral therapy

  Individuals with bipolar disorder and other severe mental illnesses are more likely to have higher rates of HIV infection compared to the general population, possibly due to impulsive behaviors or substance use disorders. Individuals with bipolar disorder usually require long-term treatment with various psychotropic medications. Patients with bipolar disorder, who adhere to their bipolar medications, are also more likely to adhere to their antiretroviral treatment for HIV infection, suggests a new study using prescription refill data.

  06 March 2012 | Agency for Healthcare Research and Quality

• Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV

  After HIV diagnosis, timely entry into HIV medical care and retention in that care are essential to the provision of effective antiretroviral therapy (ART). ART adherence is among the key determinants of successful HIV treatment outcome and is essential to minimize the emergence of drug resistance.

  05 March 2012 | Annals of Internal Medicine

• IAPAC Guidelines Offer Recommendations to Optimize Entry into and Retention in HIV Care, and Treatment Adherence

  The guidelines include recommendations in several key areas, including: entry into and retention in care; monitoring adherence to HIV care and antiretroviral therapy (ART); interventions to improve ART adherence including those involving choice of ART regimens; adherence tools for patients; education and counseling; and health system and service delivery interventions.

  05 March 2012 | International Association of Physicians in AIDS Care

• Zimbabwe: Compliance - Arvs' Golden Rule

  [The Herald] Charity had been on Anti Retroviral Therapy for the past five years. She had regained her weight and was no longer ill, as was the case years before commencing ART. She has vowed never to stop taking the drugs.

  23 February 2012 | AllAfrica

• New 'smart pills' signal your iPhone

  Imagine a "smart pill" containing a biodegradable electronic chip that monitors how your body responds to the medicine, broadcasts the information to your iPhone, which then emails the information to your physician. It may sound like science fiction, but drug companies have been studying just such an approach, according to an article in the current edition of ACS's Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.

  15 February 2012 | Eurekalert Medicine & Health

• Medicalizing HIV: Will Social Services Get Squeezed Out?

  OAKLAND Calif Major medical breakthroughs over the past year in the treatment of HIVAIDS are setting off some surprising alarm bells While praised for their lifesaving potential they are causing a change in the dynamics of HIVAIDS care they are causing a change in the dynamics of HIV/AIDS care – a shift that may squeeze out social services needed to support patients while they’re in treatment.

  20 January 2012 | New American Media

More news